Tin tức & Cập nhật

Prior vaccinations may have AD risk-lowering benefit
Prior vaccinations may have AD risk-lowering benefit
22 Aug 2023
SC on par with IV rituximab in CD20+ diffuse large B-cell lymphoma
SC on par with IV rituximab in CD20+ diffuse large B-cell lymphoma
22 Aug 2023 bởiStephen Padilla

In patients with previously untreated CD20+ diffuse large B-cell lymphoma (DLBCL), treatment with subcutaneous (SC) rituximab is not inferior to intravenous (IV) rituximab in terms of serum trough levels, efficacy, and tolerability, as shown in a study presented at EHA 2023.

SC on par with IV rituximab in CD20+ diffuse large B-cell lymphoma
22 Aug 2023
How does obesity affect survival in patients with multiple myeloma?
How does obesity affect survival in patients with multiple myeloma?
22 Aug 2023 bởiStephen Padilla

Obesity does not seem to have any significant impact on clinical outcomes, particularly survival, in patients with multiple myeloma (MM), according to a study presented at EHA 2023. However, obese MM patients aged <65 years tend to have a shorter overall survival (OS) than those with normal weight.

How does obesity affect survival in patients with multiple myeloma?
22 Aug 2023
Which factors predict sustained seizure reduction with brivaracetam in focal epilepsy?
Which factors predict sustained seizure reduction with brivaracetam in focal epilepsy?
22 Aug 2023

In patients with focal epilepsy, seizure frequency at baseline and the number of previous antiseizure medications (ASMs) used can predict sustained reduction in seizure frequency with adjunctive brivaracetam, according to data from the BRIVAFIRST study.

Which factors predict sustained seizure reduction with brivaracetam in focal epilepsy?
22 Aug 2023
Doxorubicin, hypertension predict lower breast cancer recurrence
Doxorubicin, hypertension predict lower breast cancer recurrence
21 Aug 2023 bởiStephen Padilla

Certain comorbidities such as hypertension and diabetes mellitus (DM), along with locally advanced stage at diagnosis and systemic treatment received (ie, doxorubicin), are significantly associated with tumour recurrences among patients with breast cancer, according to a study presented at the recent ASCO Breakthrough 2023.

Doxorubicin, hypertension predict lower breast cancer recurrence
21 Aug 2023
Financial aid helps improve survival of indigent patients with breast cancer
Financial aid helps improve survival of indigent patients with breast cancer
20 Aug 2023